Coleman Lindsley Lab
  • HOME
  • PEOPLE
  • RESEARCH
    • Stem Cell Transplantation
    • Bone Marrow Failure and MDS/AML Predisposition
    • Pathways of leukomogenesis
    • Hematologic Malignancies Data Repository
  • PUBLICATIONS
  • CONTACT
  • JOIN THE LAB
  • FUNDING SUPPORT
  • LAB PORTAL

Open positions available in the Lindsley Lab
contact for more information

The Lindsley Lab brings together physicians and scientists who are driven to improve outcomes for patients with blood cancers. The central focus of the laboratory is on myeloid malignancies [such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)] and bone marrow failure syndromes. We use genomic technologies to study samples from patients with these diseases as a way to define pathways of disease initiation and progression, and to identify mutations that predict outcomes after various treatments. We use mouse and cell line models to dissect the mechanisms by which these gene mutations cause disease.
Improving outcomes in stem cell transplantation


Understanding Bone Marrow Failure and MDS/AML Predisposition Syndromes
Defining genetic pathways of myeloid disease progression
The Hematologic Malignancies Data Repository (HMDR)
Picture
Picture
Picture
Picture

 HOME | PEOPLE | RESEARCH | PUBLICATIONS | SUPPORT | CONTACT | JOIN THE LAB

©2019 Lindsley Lab at Dana-Farber Cancer Institute
  • HOME
  • PEOPLE
  • RESEARCH
    • Stem Cell Transplantation
    • Bone Marrow Failure and MDS/AML Predisposition
    • Pathways of leukomogenesis
    • Hematologic Malignancies Data Repository
  • PUBLICATIONS
  • CONTACT
  • JOIN THE LAB
  • FUNDING SUPPORT
  • LAB PORTAL